NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $219,425 | – | 119,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Myriad Asset Management Ltd. | 17,500,000 | $29,890,000 | 4.31% |
SSI INVESTMENT MANAGEMENT LLC | 8,987,000 | $15,319,000 | 1.18% |
CSS LLC/IL | 14,955,000 | $25,561,000 | 1.09% |
SHENKMAN CAPITAL MANAGEMENT INC | 3,983,000 | $6,799,000 | 0.82% |
Verition Fund Management LLC | 6,425,000 | $10,968,000 | 0.39% |
ADVENT CAPITAL MANAGEMENT /DE/ | 9,495,000 | $16,214,000 | 0.33% |
MACKAY SHIELDS LLC | 21,609,000 | $36,877,000 | 0.28% |
WOLVERINE ASSET MANAGEMENT LLC | 12,776,000 | $21,819,000 | 0.25% |
Calamos Advisors LLC | 24,100,000 | $41,405,000 | 0.23% |
OAKTREE CAPITAL MANAGEMENT LP | 8,895,000 | $15,184,000 | 0.20% |